6'-n-alkyl and 6',6'-di-n-alkyl derivatives of fortimicins a and b
CA 1111052 A · Owner: Abbott Laboratories · Inventors: Martin, Jerry R.; Dunnigan, Daniel A.; Tadanier, John S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel fortimicin derivatives having antibiotic activity represented by the formula, wherein R1 is loweralkyl R2 is hydrogen or loweralkyl and, R3 is selected from the group consisting of hydrogen acyl, hydroxyacyl, aminoacyl, N-monoloweralkylaminoacyl N,N-di, loweralkylaminoacyl, hydroxy-substituted aminoacyl or an aminoacid residue, loweralkyl, hydroxyloweralkyl aminolower-, alkyl, N-monoloweralkylaminoloweralkyl N,N-diloweralkyl-, aminoloweralkyl or hydroxy-substituted aminoloweralkyl; and the pharmaceutically acceptable salts thereof inter-, mediates useful in their preparation compositions employing, the compounds and methods of using the compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted October 20, 1981. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended October 20, 1998.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.